What is histotripsy and should I get that for liver cancer? What else is it good for? Pancreatic
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Histotripsy is a relatively new non-invasive ultrasound-based therapy that is being explored for the treatment of certain types of cancer, including liver and pancreatic cancer. Here's a brief overview:
For Liver Cancer:
- Histotripsy uses focused ultrasound waves to mechanically destroy targeted tumor tissue in the liver without damaging surrounding healthy tissue.
- It is still considered an experimental treatment for liver cancer, with ongoing clinical trials to evaluate its safety and effectiveness.
- Histotripsy may be an option for some patients with liver cancer, but it's important to discuss the potential benefits and risks with your oncologist. They can help determine if you are a suitable candidate.
For Pancreatic Cancer:
- Histotripsy is also being investigated as a potential treatment for pancreatic cancer, though the research is still in early stages.
- The goal is to use the focused ultrasound to break down pancreatic tumor tissue without harming nearby organs.
- Pancreatic cancer is a challenging disease, and histotripsy may offer a new approach, but more clinical data is needed.
It's important to note that histotripsy is not yet a standard of care treatment for liver or pancreatic cancer. While the research is promising, it's crucial to have an in-depth discussion with your oncology team to understand if it may be a suitable option for your specific situation. They can provide personalized guidance based on your medical history, stage of cancer, and overall health.
I would recommend focusing on the treatment approaches recommended by your oncology team, as they will be best equipped to determine the most appropriate course of action for your care. Please don't hesitate to ask them about histotripsy or any other emerging therapies you may have come across.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2